APPROACH Study

Mosaic Design APPROACH, a preventive vaccine study, seeks to address more than one clade by Jeannie Wraight Over the past thirty-plus years, strategies such as Treatment as...

Women & PrEP

LifeGuide It's a Man's World Research on women & PrEP needs to keep pace by Jeannie Wraight   Whereas HIV cure and HIV prevention are two very different...

Novel Cure Research Supported by amfAR

Deciphering the Puzzle A new round of amfAR's Countdown to a Cure initiative grants support novel cure research by Jeannie Wraight amfAR has awarded a new round...

HIV reportedly “cured” in patient in London

For only the second time in the history of the AIDS pandemic, a patient with HIV in London seems to have been freed of...

Counting Cures

Destination: Cure by Jeannie Wraight Counting Cures Before we start tallying “cures,” let’s strive to define what we mean by “cured?”   Several months ago a media frenzy...

Talking “Cure”

Nobel Prize Laureate and world renowned HIV researcher Françoise Barré-Sinoussi recently made the statement that she does not believe an HIV cure is possible....

Cure Research: CROI 2018

Fast Look Cure research highlights from CROI 2018 by Jeannie Wraight The Conference on Retroviruses and Opportunistic Infections (CROI) provides an annual snapshot of the year’s most...

AR-12: One Drug Candidate, Many Possibilities

One Drug, Many Possibilities A new agent may assist in the fight against HIV and other viruses by Jeannie Wraight Every once in a while I come...

4 CROI Briefs

Another year of the Conference on Retroviruses and Opportunistic Infections (CROI 2016) has come to pass. Here are a few less publicized but important...

Broad Spectrum Antivirals: Part II

Beyond One Bug, One Drug Broad spectrum antivirals shift the drug model paradigm, part II by Jeannie Wraight In the October issue of A&U, Destination: Cure explored...

LATEST POSTS

Ron B: Cover Story

“You had me at Angels in America,” I tell Ron B. when I see her at the Manhattan Neighborhood Network studios, in New York...